SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE:DPLO shares against Diplomat Pharmacy over alleged Violations of Securities Laws.
Investors who purchased shares of Diplomat Pharmacy Inc (NYSE:DPLO) in September 2014 or earlier and continue to hold any of those NYSE: DPLO shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On November 10, 2016, a lawsuit was filed against Diplomat Pharmacy Inc over alleged securities laws violations. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Diplomat Pharmacy Inc lacked adequate internal controls over its financial reporting, that as a result Diplomat Pharmacy Inc could not adequately calculate DIR fees, that the Company’s hepatitis C segment was not performing as previously disclosed to investors, that and therefore, Diplomat Pharmacy Inc had overstated its full-year 2016 guidance, and that that, as a result of the foregoing, defendants’ statements about Diplomat Pharmacy Inc’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On April 11, 2017, an amended complaint was filed and on May 24, 2017 the defendants filed the motion to dismiss the case. A hearing on the motion to dismiss was scheduled for November 30, 2017, however the court has not ruled on the motion yet.
Those who purchased Diplomat Pharmacy Inc (NYSE:DPLO) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.